InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,990.24
(
0.29%
)
US TECH 100
20,511.60
(
-0.15%
)
Dow Jones
43,946.35
(
0.50%
)
Brent Oil
73.56
(
-2.52%
)
Bitcoin
76,288.77
(
0.51%
)
Post# of 118242
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

indievestments

Send PM Follow Ignore
Followers 0
Posts 29
Boards Moderated 0
Alias Born 01/07/2015

indievestments

Re: 2morrowsGains post# 61468

Tuesday, 05/07/2019 2:22:15 PM

Tuesday, May 07, 2019 2:22:15 PM

Post# of 118242
Sorry, I don’t check this board much but came to see if you were posting anything new about ATOM. Great move.

I like that SRTS is hanging tough here. Warrants expire in a month. iCAD said IORT sales were strong/accelerating on the heels of more market awareness following a few global IORT clinical studies. They are also moving into prostrate cancer — performed first procedure, and are developing custom balloon applicators.

Hopefully SRTS will tell similar story and has 2+ more IRB placements done by now.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up